Compare USGO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USGO | RPID |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5M | 84.8M |
| IPO Year | 2023 | 2021 |
| Metric | USGO | RPID |
|---|---|---|
| Price | $9.20 | $1.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.75 | $8.00 |
| AVG Volume (30 Days) | 66.2K | ★ 222.2K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.12 | 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $7.16 | $1.52 |
| 52 Week High | $17.98 | $4.94 |
| Indicator | USGO | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 38.58 |
| Support Level | $8.73 | N/A |
| Resistance Level | $10.50 | $2.18 |
| Average True Range (ATR) | 0.49 | 0.14 |
| MACD | 0.13 | -0.03 |
| Stochastic Oscillator | 82.00 | 20.59 |
US Goldmining Inc is a mineral exploration company with a focus on the exploration and development of a project located in Alaska, USA. The company's primary asset is the 100%-owned Whistler exploration property located in Alaska, USA. It operates and reports in one segment, which focuses on the exploration and development of mineral properties.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.